Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study-NSGO-AVANOVA2/ENGOT-OV24.

Mansoor Raza Mirza, Elisabeth Avall-Lundqvist, Michael J. Birrer, Rene dePont Christensen, Gitte-Bettina Nyvang, Susanne Malander, Maarit Anttila, Theresa Louise Werner, Bente Lund, Gabriel Lindahl, Sakari Hietanen, Ulla Peen, Maria Dimoula, Henrik Roed, Anja Or Knudsen, Louisa Boufercha, Synnove Staff, Anders Krog Vistisen, Line Bjorge, Johanna Unelma Maenpaa

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer5505
TidsskriftJournal of Clinical Oncology
Vol/bind37
Udgave nummer15, Suppl.
ISSN0732-183X
DOI
StatusUdgivet - 20 maj 2019
BegivenhedAnnual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, USA
Varighed: 31 maj 20194 jun. 2019

Konference

KonferenceAnnual Meeting of the American Society of Clinical Oncology (ASCO)
LandUSA
ByChicago
Periode31/05/201904/06/2019

Citationsformater